Advocacy in support of Medicare Coverage for Dialysis-Related Amyloidosis (DRA) Treatment. H.R. 4055 (119th Cong.).
Literal federal measure citations: H.R. 4055
2025 · 4th Quarter (Oct 1 - Dec 31)
KANEKA PHARMA AMERICA, LLC
Filed by KING & SPALDING LLP.
Open official filingSource-reported fields
Filing overview
- Type
- 4th Quarter - Termination
- Posted
- Jan 19, 2026
- Income
- $40,000.00
- Expenses
- Not reported
- Registrant
- KING & SPALDING LLP
- Filing UUID
- 18100e65-91ab-4837-8eae-12ef78b392a5
- Termination date
- Dec 31, 2025
Literal source text
Lobbying issues and bill citations
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.